What We Do
When someone suffers a serious brain injury there are currently no drugs available to alleviate the cognitive, functional, and neurobehavioral effects.
NTS is developing a portfolio of products designed to address these life impairing damages.
Chief Operating Officer
Brent Miller, PhD
VP Product & Portfolio Management
Dean Murphy, RAC
VP Regulatory Affairs & Quality Assurance
David Poulsen, PhD
Chief Science Officer
David H. Fater
Chief Administrative Officer & Finance Director
NeuroTrauma Sciences LLC is a funded, privately held company. Additional information on our investors may be made available upon request.